Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-03-08 @ 11:20 PM
Study NCT ID:
NCT05390632
Status:
UNKNOWN
Last Update Posted:
2023-03-03
First Post:
2022-05-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
Sponsor:
Peking University Cancer Hospital & Institute
Organization:
Study Overview
Official Title:
Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
Status:
UNKNOWN
Status Verified Date:
2023-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigating the performance of 18F-FDG PET/CT and PET/MRI in lymphomas
Detailed Description:
In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by 18F-FDG PET (PET/CT and PET/MR). Prior to treatment, all patients will undergo whole-body 18F-FDG PET/CT and PET/MR. The methods' efficiency was compared in the diagnosis of lymph node (LN) and organ involvement.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: